disopyramide has been researched along with Nephrotic Syndrome in 2 studies
Disopyramide: A class I anti-arrhythmic agent (one that interferes directly with the depolarization of the cardiac membrane and thus serves as a membrane-stabilizing agent) with a depressant action on the heart similar to that of guanidine. It also possesses some anticholinergic and local anesthetic properties.
disopyramide : A monocarboxylic acid amide that is butanamide substituted by a diisopropylamino group at position 4, a phenyl group at position 2 and a pyridin-2-yl group at position 2. It is used as a anti-arrhythmia drug.
Nephrotic Syndrome: A condition characterized by severe PROTEINURIA, greater than 3.5 g/day in an average adult. The substantial loss of protein in the urine results in complications such as HYPOPROTEINEMIA; generalized EDEMA; HYPERTENSION; and HYPERLIPIDEMIAS. Diseases associated with nephrotic syndrome generally cause chronic kidney dysfunction.
| Excerpt | Relevance | Reference |
|---|---|---|
| "1 Plasma protein binding of disopyramide was determined twice in plasma from seven patients with severe nephrotic syndrome when the disease activity was markedly different for each patient (mean +/- s." | 7.67 | Disopyramide protein binding in plasma from patients with nephrotic syndrome during the exacerbation and remission phases. ( Echizen, H; Ishizaki, T; Saima, S, 1987) |
| "The plasma protein binding of disopyramide (D) was determined in seven patients with cirrhosis, six with nephrotic syndrome, and seven healthy subjects." | 7.67 | Protein binding of disopyramide in liver cirrhosis and in nephrotic syndrome. ( Echizen, H; Ishizaki, T; Saima, S; Umeda, N, 1986) |
| "1 Plasma protein binding of disopyramide was determined twice in plasma from seven patients with severe nephrotic syndrome when the disease activity was markedly different for each patient (mean +/- s." | 3.67 | Disopyramide protein binding in plasma from patients with nephrotic syndrome during the exacerbation and remission phases. ( Echizen, H; Ishizaki, T; Saima, S, 1987) |
| "The plasma protein binding of disopyramide (D) was determined in seven patients with cirrhosis, six with nephrotic syndrome, and seven healthy subjects." | 3.67 | Protein binding of disopyramide in liver cirrhosis and in nephrotic syndrome. ( Echizen, H; Ishizaki, T; Saima, S; Umeda, N, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Echizen, H | 2 |
| Saima, S | 2 |
| Ishizaki, T | 2 |
| Umeda, N | 1 |
2 other studies available for disopyramide and Nephrotic Syndrome
| Article | Year |
|---|---|
Disopyramide protein binding in plasma from patients with nephrotic syndrome during the exacerbation and remission phases.
Topics: Adult; Body Weight; Disopyramide; Female; Humans; Kinetics; Male; Middle Aged; Nephrotic Syndrome; O | 1987 |
Protein binding of disopyramide in liver cirrhosis and in nephrotic syndrome.
Topics: Adult; Aged; Analysis of Variance; Blood Proteins; Disopyramide; Female; Fluorescence Polarization; | 1986 |